CHC LABS INC.
|
TOTAL CALCIUM (82310) |
|
|
135 |
Sarcoidosis |
|
140.0-208.91 |
Malignant neoplasms |
|
252.0 |
Hyperparathyroidism |
|
252.1 |
Hypoparathyroidism |
|
255.4 |
Corticoadrenal insufficiency |
|
260-269.9 |
Nutritional deficiencies |
|
275.41 |
Hypocalcemia |
|
275.42 |
Hypercalcemia |
|
275.49 |
Other disorders of calcium metabolism |
|
276.0-276.9 |
Disorders of fluid, electrolyte, and acid-base balance |
|
278.4 |
Hypervitaminosis D |
|
293.0-293.1 |
Acute and subacute delirium (confusion) |
|
298.9 |
Unspecified psychosis |
|
368.13 |
Visual discomfort |
|
368.2 |
Diplopia |
|
427.0-427.9 |
Cardiac dysrhythmias |
|
519.1 |
Other diseases of trachea and bronchus not elsewhere classified (bronchospasms) |
|
564.00-564.09 |
Constipation |
|
577.0-577.1 |
Pancreatitis |
|
579.0-579.9 |
Intestinal malabsorption |
|
580.0-588.9 |
Nephritis, nephritic syndrome, and nephrosis |
|
728.89 |
Other disorders of muscle, ligament, and fascia (rhabdomyolysis) |
|
728.9 |
Unspecified disorder of muscle, ligament, and fascia (muscle weakness and soreness) |
|
733.90 |
Disorder of bone and cartilage, unspecified (bone pain) |
|
780.1 |
Coma |
|
780.39 |
Other convulsions |
|
780.79 |
Other malaise and fatigue |
|
781.0 |
Abnormal involuntary movements |
|
781.7 |
Tetany |
|
782.0 |
Disturbance of skin sensation (parasthesias) |
|
783.0 |
Anorexia |
|
783.5 |
Polydipsia |
|
785.59 |
Other shock without mention of trauma |
|
787.01-787.03 |
Nausea and vomiting |
|
787.2 |
Dysphagia |
|
788.42 |
Polyuria |
|
E934.2 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, anticoagulants |
|
E936.3 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, other and unspecified anticonvulsants |
|
E943.3 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, other cathartics, including intestinal atonia drugs |
|
E944.4 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, other diuretics |
|
E944.5 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, electrolytic, caloric, and water-balance agents |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|